Arance-Criado, E.; Vázquez-Alonso, F.; García-Iglesias, M.Y.; López-Cintas, R.; Martín-Esteban, S.; López-Torres, G.; Cortés-Valverde, A.I.; Alvarez-Cubero, M.J.; Martínez-Gonzalez, L.J.
Determination of Expression Signature and Proportion of mtDNA in Plasma Fractions in Patients with Renal Cell Carcinoma. Proceedings 2021, 76, 9.
https://doi.org/10.3390/IECGE-07148
AMA Style
Arance-Criado E, Vázquez-Alonso F, García-Iglesias MY, López-Cintas R, Martín-Esteban S, López-Torres G, Cortés-Valverde AI, Alvarez-Cubero MJ, Martínez-Gonzalez LJ.
Determination of Expression Signature and Proportion of mtDNA in Plasma Fractions in Patients with Renal Cell Carcinoma. Proceedings. 2021; 76(1):9.
https://doi.org/10.3390/IECGE-07148
Chicago/Turabian Style
Arance-Criado, Elena, Fernando Vázquez-Alonso, Mª Yarmila García-Iglesias, Rocío López-Cintas, Sara Martín-Esteban, Ginesa López-Torres, Ana Isabel Cortés-Valverde, María Jesús Alvarez-Cubero, and Luis Javier Martínez-Gonzalez.
2021. "Determination of Expression Signature and Proportion of mtDNA in Plasma Fractions in Patients with Renal Cell Carcinoma" Proceedings 76, no. 1: 9.
https://doi.org/10.3390/IECGE-07148
APA Style
Arance-Criado, E., Vázquez-Alonso, F., García-Iglesias, M. Y., López-Cintas, R., Martín-Esteban, S., López-Torres, G., Cortés-Valverde, A. I., Alvarez-Cubero, M. J., & Martínez-Gonzalez, L. J.
(2021). Determination of Expression Signature and Proportion of mtDNA in Plasma Fractions in Patients with Renal Cell Carcinoma. Proceedings, 76(1), 9.
https://doi.org/10.3390/IECGE-07148
